These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 23257365)

  • 21. The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation.
    De Nunzio C; Kramer G; Marberger M; Montironi R; Nelson W; Schröder F; Sciarra A; Tubaro A
    Eur Urol; 2011 Jul; 60(1):106-17. PubMed ID: 21497433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study.
    Proctor MJ; Morrison DS; Talwar D; Balmer SM; Fletcher CD; O'Reilly DS; Foulis AK; Horgan PG; McMillan DC
    Eur J Cancer; 2011 Nov; 47(17):2633-41. PubMed ID: 21724383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical outcomes after combined therapy with dutasteride plus tamsulosin or either monotherapy in men with benign prostatic hyperplasia (BPH) by baseline characteristics: 4-year results from the randomized, double-blind Combination of Avodart and Tamsulosin (CombAT) trial.
    Roehrborn CG; Barkin J; Siami P; Tubaro A; Wilson TH; Morrill BB; Gagnier RP
    BJU Int; 2011 Mar; 107(6):946-54. PubMed ID: 21332630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of diabetes and obesity in outcomes of the candesartan antihypertensive survival evaluation in Japan (CASE-J) trial.
    Nakao K; Hirata M; Oba K; Yasuno S; Ueshima K; Fujimoto A; Ogihara T; Saruta T;
    Hypertens Res; 2010 Jun; 33(6):600-6. PubMed ID: 20379187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preoperative metastatic status, level of thrombus and body mass index predict overall survival in patients undergoing nephrectomy and inferior vena cava thrombectomy.
    Spiess PE; Kurian T; Lin HY; Rawal B; Kim T; Sexton WJ; Pow-Sang JM
    BJU Int; 2012 Dec; 110(11 Pt B):E470-4. PubMed ID: 22519938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significance of histological prostatitis in patients with urinary retention and underlying benign prostatic hyperplasia or adenocarcinoma of the prostate.
    van Vuuren SP; Heyns CF; Zarrabi AD
    BJU Int; 2012 Apr; 109(8):1194-7. PubMed ID: 21851551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of benign prostatic hyperplasia by Prostiva(®): about a series of 76 cases].
    Le Gal S; Le Toquin-Bernard S; Hurel S; Doerfler A; Salomon L; De La Taille A; Bensadoun H
    Prog Urol; 2011 Jun; 21(6):417-25. PubMed ID: 21620303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function.
    Li MK; Garcia L; Patron N; Moh LC; Sundram M; Leungwattanakij S; Pripatnanont C; Cheng C; Chi-Wai M; Loi-Cheong N
    BJU Int; 2008 Jan; 101(2):197-202. PubMed ID: 18005205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
    Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
    BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preoperative cardiac risk index predicts long-term mortality and health status.
    Hoeks SE; op Reimer WJ; van Gestel YR; Smolderen KG; Verhagen H; van Domburg RT; van Urk H; Poldermans D
    Am J Med; 2009 Jun; 122(6):559-65. PubMed ID: 19376487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of body mass index on clinical outcomes in triple-negative breast cancer.
    Ademuyiwa FO; Groman A; O'Connor T; Ambrosone C; Watroba N; Edge SB
    Cancer; 2011 Sep; 117(18):4132-40. PubMed ID: 21387276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Class I obesity is paradoxically associated with decreased risk of postoperative stroke after carotid endarterectomy.
    Jackson RS; Black JH; Lum YW; Schneider EB; Freischlag JA; Perler BA; Abularrage CJ
    J Vasc Surg; 2012 May; 55(5):1306-12. PubMed ID: 22542344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Body mass index and risk of BPH: a meta-analysis.
    Wang S; Mao Q; Lin Y; Wu J; Wang X; Zheng X; Xie L
    Prostate Cancer Prostatic Dis; 2012 Sep; 15(3):265-72. PubMed ID: 22183774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interstitial laser coagulation for management of benign prostatic hyperplasia: long-term follow-up.
    Terada N; Arai Y; Okubo K; Ichioka K; Matsui Y; Yoshimura K; Terai A
    Int J Urol; 2004 Nov; 11(11):978-82. PubMed ID: 15509201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of morbid obesity and weight change over time with cardiovascular survival in hemodialysis population.
    Kalantar-Zadeh K; Kopple JD; Kilpatrick RD; McAllister CJ; Shinaberger CS; Gjertson DW; Greenland S
    Am J Kidney Dis; 2005 Sep; 46(3):489-500. PubMed ID: 16129211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic kidney disease among men with lower urinary tract symptoms due to benign prostatic hyperplasia.
    Hong SK; Lee ST; Jeong SJ; Byun SS; Hong YK; Park DS; Hong JY; Son JH; Kim C; Jang SH; Lee SE
    BJU Int; 2010 May; 105(10):1424-8. PubMed ID: 19874305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of transurethral resection of prostate on the quality of life of patients with benign prostatic hyperplasia.
    O'Sullivan M; Murphy C; Deasy C; Iohom G; Kiely EA; Shorten G
    J Am Coll Surg; 2004 Mar; 198(3):394-403. PubMed ID: 14992742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac procedures in patients with a body mass index exceeding 45: outcomes and long-term results.
    Tyson GH; Rodriguez E; Elci OC; Koutlas TC; Chitwood WR; Ferguson TB; Kypson AP
    Ann Thorac Surg; 2007 Jul; 84(1):3-9; discussion 9. PubMed ID: 17588372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The association of prostate stem cell antigen (PSCA) mRNA expression and subsequent prostate cancer risk in men with benign prostatic hyperplasia following transurethral resection of the prostate.
    Zhigang Z; Wenlu S
    Prostate; 2008 Feb; 68(2):190-9. PubMed ID: 18076024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low 25-OH vitamin D is associated with benign prostatic hyperplasia.
    Haghsheno MA; Mellström D; Behre CJ; Damber JE; Johansson H; Karlsson M; Lorentzon M; Peeker R; Barret-Connor E; Waern E; Sundh V; Ohlsson C; Hammarsten J
    J Urol; 2013 Aug; 190(2):608-14. PubMed ID: 23399651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.